Pharmafile Logo
Pharmafocus logo
Advanced Search
Novo image

Novo Nordisk obesity drug is launched in the US

April 23, 2015
Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

News
Gilead image

Gilead presents new Sovaldi data

April 23, 2015
Sales and Marketing GS-5816, GS-9857, Gilead, NS3/4A, SVR12, hepatitis C, sofosbuvir, sovaldi

Gilead is looking to several new studies to support future new Sovaldi combinations and broadened treatment groups for its hepatitis …

News

Boehringer assures future growth following sales drop

April 23, 2015
Sales and Marketing Boehringer, COPD, Glyxambi, Striverdi Respimat, empagliflozin, empagliflozin/linagliptin, financials, full year, jardiance, nintedanib, ofev, olodaterol, results

Boehringer says it is positioned for future growth in the wake of filing a decline in profit for 2014 and …

News
jeroen_tonnaer

Cristal Therapeutics hires chief business officer from Merck

April 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck

Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …

Appointment

Study reveals true scale of falsified medicines problem

April 22, 2015
Manufacturing and Production, Sales and Marketing Counterfeiting, fake, falsified medicines, health, pharma, supply chain

The full scope and prevalence of counterfeit medicines is poorly understood, according to a study of global pharma supply chains. …

News
Amgen image

Amgen files high earnings for Q1

April 22, 2015
Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis

Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …

News
Teva image

Teva faces $512m fine in generic Provigil row

April 22, 2015
Sales and Marketing Cephalon, Mylan, Teva, generic, modafinil, provigil

Teva has agreed to a record $512 million settlement in a ‘pay-to-delay’ row over generic versions of its drug Provigil. …

News
Roche image

Roche buoyed by cancer drug sales

April 22, 2015
Sales and Marketing Actemra, Cancer, Esbriet, Esbriet., MabThera, Q1, Rituxan, RoActemra, Roche, Xolair, avastin, oncology

Pharma’s biggest cancer drugs maker Roche has reported strong sales growth on the back of its oncology portfolio for its …

News
Pfizer image

Two oncology successes for Pfizer

April 22, 2015
Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology

Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …

News
Boehringer image

Boehringer Ingelheim and Bayer ‘taking the lead’ in social media

April 22, 2015
Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld

Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …

News
goran_ando

EUSA Pharma appoints chief executive and director

April 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley

Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …

Appointment
Teva image

Teva moves to buy Mylan

April 21, 2015
Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …

News
Pfizer image

Merck KGaA and Pfizer alliance begins lung cancer study

April 21, 2015
Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo

Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …

News
Daiichi image

Daiichi Sankyo to sell Sun Pharma stake

April 21, 2015
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics

Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …

News

Novartis MS drug scores positive late-stage trial result

April 21, 2015
Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis

People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …

News
Apps image

UK firm unveils respiratory apps

April 21, 2015
Medical Communications, Sales and Marketing Activ8rlives, Aseptika, SENSOR, communications, digital

Cambridgeshire-based healthcare tech firm Aseptika has made its suite of apps available to support studies in respiratory research. The UK …

News
vivian_huang

Four join the ranks of IDEA Pharma

April 21, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang

IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …

Appointment
Sanofi image

Sanofi sues decision aid maker for ‘injurious falsehood’

April 20, 2015
Medical Communications, Sales and Marketing Diagnosia, Sanofi, metamizole, tech

A tech start-up says it is being sued by pharma giant Sanofi for presenting facts about a drug’s side effects …

News
Merck image

Merck seeks new Keytruda indication in US

April 20, 2015
Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab

Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …

News

Round one to Pfizer in Zoloft lawsuit battle

April 20, 2015
Sales and Marketing Pfizer, Zoloft, antidepressant, birth defects, law suits, legal, sertraline

Pfizer’s Zoloft did not cause a young boy’s birth defects, a jury has ruled, in the first of a thousand …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026